Najarian graduated from the University of Michigan, Ann Arbor with a Bachelor of Science in Microbiology with Highest Honors
and Highest Distinction. Then, after spending a year inventing an electronics device, "Remote Device for Silent
Awakening," which received U.S. patent number 6,151,278, he went to work as a biochemist at Schering Plough in Kenilworth,
NJ. During his year there, his research group discovered the mechanism of action of a novel antibiotic, evernimicin,
and won the company's highest research award, the Presidential Award for Research.
then went to medical school at the University of Virginia in Charlottesville. After finishing medical school he completed
a 1 year internship in internal medicine at Montefiore--Albert Einstein College of Medicine, NY, and then enrolled at U.M.D.N.J.
in New Brunswick, NJ for his dermatology residency. He then completed a 1 year skin cancer surgery fellowship at the
Roswell Park Cancer Institute, Buffalo, NY, which was sponsored by the American College of Mohs Surgery. Subsequently,
he trained in cosmetic eyelid surgery at St. Louis University and the Jules Stein Eye Institute at U.C.L.A..
Dr. Najarian opened a private practice in his hometown
of Randolph, NJ, where he currently works Monday through Friday. He serves on the editorial board of the Journal of
the American Academy of Dermatology. He is certified by the American Board of Dermatology and is an Associate of the
American College of Mohs Surgery. Dr. Najarian is also a member of the American Contact Dermatitis Society.